Preoperative intra-aortic balloon pump in patients with ST-elevation myocardial infarction undergoing urgent cardiac

Veemal V Hemradj1,2, Alexander J Spanjersberg3, Marit Buitenhuis1

  • 1Department of Cardiology, Isala Hospital, Zwolle, The Netherlands.

Insights

For ST-elevation myocardial infarction (STEMI) patients needing urgent coronary artery bypass grafting (CABG), preoperative intra-aortic balloon pump (IABP) insertion is linked to better survival. This study found IABP use reduced 30-day mortality in this high-risk group.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Devices

Background:

  • Intra-aortic balloon pump (IABP) use in ST-elevation myocardial infarction (STEMI) without cardiogenic shock is not proven to lower mortality.
  • Preoperative IABP insertion in STEMI patients undergoing urgent coronary artery bypass grafting (CABG) has shown potential mortality benefits.

Purpose of the Study:

  • To investigate the impact of preoperative IABP use on 30-day mortality in STEMI patients who underwent urgent CABG.

Main Methods:

  • A single-center study of consecutive STEMI patients undergoing urgent CABG from 2000-2018.
  • Comparison of 30-day mortality between patients with and without preoperative IABP.
  • Multivariable and subgroup analyses, including propensity score and inverse probability treatment weighting, were used to adjust for confounders.

Main Results:

  • 246 patients were analyzed; 171 received a preoperative IABP.
  • The preoperative IABP group had higher rates of cardiogenic shock, persistent ischemia, and reduced left ventricular function.
  • After adjustment for confounders, preoperative IABP was associated with a reduced 30-day mortality (RR 0.52, 95% CI 0.30-0.88).

Conclusions:

  • Preoperative IABP insertion is associated with reduced mortality in STEMI patients undergoing urgent CABG.
  • IABP may be beneficial in selected high-risk STEMI patients undergoing urgent CABG.
Abstract